 YAVNE, Israel, Sept. 03, 2021 GLOBE NEWSWIRE -- MediWound Ltd. Nasdaq: MDWD the Company, a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that management will present at the following investor conferences during the month of September 2021. 